Atorvastatin Calcium
Product Images NDC 53002-2440

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 53002-2440). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Atorvastatin Calcium Figure 1)

A line graph showing cumulative incidence (%) over time (up to 3.5 years) comparing Atorvastatin and Placebo groups. The incidence is plotted on the Y-axis and years on the X-axis. Atorvastatin shows a lower cumulative incidence than Placebo throughout the period. A hazard ratio of 0.64 (0.50-0.83) with a p-value of 0.0005 is indicated on the graph.*

FDA Label Image

Figure (Atorvastatin Calcium Figure 2)

A line graph comparing cumulative hazard percentages over time in years for Atorvastatin versus Placebo. The x-axis shows time to first primary endpoint through four years of follow-up, and the y-axis shows cumulative hazard percentage. Atorvastatin line shows a lower cumulative hazard than Placebo. The graph includes hazard ratio (HR=0.63) and p-value (0.001).*

FDA Label Image

Figure (Atorvastatin Calcium Figure 3)

A Kaplan-Meier curve graph showing the percentage of subjects experiencing the first major cardiovascular event over five years. It compares two doses of Atorvastatin, 10 mg (dashed line) and 80 mg (solid line), with subjects on the 80 mg dose experiencing fewer events over time (hazard ratio 0.78, 95% CI 0.69-0.89, p=0.0002).*

FDA Label Image

Chemical Structure (Atorvastatin Calcium Structure)

Chemical structure of atorvastatin calcium trihydrate, showing the molecular arrangement including phenyl groups, fluorophenyl, hydroxyl groups, and calcium ion complexation as depicted in the diagram.*

FDA Label Image

Label Image (Lbl530022440)

Packaging label for Atorvastatin Calcium 40 mg tablets by RPK Pharmaceuticals, Inc. The label indicates a bottle containing 100 tablets with instructions to take one tablet daily or as directed. It includes prescription-only designation, barcode, NDC 53002-2440, lot number, expiration date, and space for prescribing and dispensing information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.